Metformin trial for vision nerve recovery in young people with MS
Treatments studied
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study tests whether metformin can help “reset” damaged nerve cells in the brain and improve vision-related nerve problems in children and young adults with multiple sclerosis. Participants are assigned to metformin or a comparison treatment in a blinded (not everyone knows which) study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 10 to 25 years (and 11 months)
- MS history with vision-nerve involvement that has lasted more than 6 months since the last attack or event
- Eye testing must show signs of nerve damage: one or more abnormal eye measurements (VEP, OCT nerve layer thickness, or a big difference between eyes)
- If you take MS medicines, the dose and medicine must have stayed the same for the last 6 months
- Blood tests must show kidneys and liver are working well enough, with no major ongoing kidney/liver problems
- Not already taking metformin, and not recently treated with steroid doses for a relapse (within 30 days)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This study tests whether metformin can slow damage to the optic nerve in people with glaucoma. It uses eye scans and vision tests to look for changes over time, aiming to help preserve sight.
This Phase 3 study tests whether metformin can improve brain function, behavior, and thinking in children and teens who were treated for certain brain tumors. You may be able to join if you meet age, time-since-treatment, language, and health/lab safety requirements.
This trial tests an experimental drug called ifenprodil to see if it can repair the protective coating (myelin) around nerves in the eye and brain for people with relapsing-remitting MS. You may join if you have a delayed visual signal in one eye and enough remaining nerve fibers to potentially rebuild myelin.
This study tests if a treatment can help repair age-related damage to the protective coating around nerves in people with multiple sclerosis. It may help improve nerve function and slow disability.
This trial tests whether the drug metformin can reduce scarring (gliosis) in the spinal cord after a recent thoraco-lumbar injury. If you've had a spinal cord injury in the past 24 hours and meet the criteria, you may be able to join.
Hear when a new Multiple Sclerosis (MS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.